Alvotech (ALVO)
Develops and manufactures biosimilar medicines through an integrated platform and partner network.
$5.84
vs last close−0.04 (−0.68%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 12.58% | 42.56M shares | |
|---|---|---|---|
| 73 holders · as of Jun 30, 2026 | |||
| Other | 87.42% | 295.66M shares | |
| remainder | |||
338.22M company shares as of Aug 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
73 holders · 42.56M shares · 23 new positions · 44 increased · 19 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Rubric Capital Management LP | 15.68M | 4.64% | +15.68Mnew | Aug 14, 2026 |
| Millennium Management LLC | 4.26M | 1.26% | +2.14M | Aug 14, 2026 |
| Bracebridge Capital, LLC | 4.04M | 1.19% | +1.33M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 3.69M | 1.09% | +279.2K | Aug 13, 2026 |
| Farallon Capital Management LLC | 2.86M | 0.85% | +2.66M | Aug 14, 2026 |
| Citadel Advisors LLC | 1.73M | 0.51% | +1.73Mnew | Sep 2, 2026 |
| Price T Rowe Associates Inc /MD/ | 1.42M | 0.42% | +21.3K | Aug 14, 2026 |
| BlackRock, Inc. | 1.33M | 0.39% | +82.1K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Aztiq Pharma Partners S.a r.l.incl. ATP Holdings ehf., Aztiq Fund I SCSp +2 more | 33.30% | 103.85M | 13D | Mar 12, 2026 |
| Celtic Holdings S.C.A.incl. Celtic Lux Holdings S.a r.l. | 27.50% | 107.45M | 13D | Jun 30, 2026 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.